VCYT (Veracyte) Other Current Payables: $0.0 Mil (As of Mar. 2026)


VCYT Veracyte Inc VCYT
75 GF Score
Price $58.72
GF Value $38.11
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Veracyte Other Current Payables?

Veracyte VCYT -2.43% 75 Other Current Payables is $0.0 Mil as of Mar. 2026. GuruFocus rates VCYT with a GF Score™ of 75/100 and a GF Value™ of $38.11 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Veracyte's Other Current Payables for the quarter that ended in Mar. 2026 was $0.0 Mil.

Veracyte Other Current Payables Related Terms

Veracyte Other Current Payables Historical Data

* Premium members only.

The historical data trend for Veracyte's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Veracyte Other Current Payables Chart

Veracyte Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Veracyte Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
VCYT
75GF Score
Veracyte Inc VCYT
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Veracyte Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of $0.0 Mil mean?
Veracyte (VCYT) has a Other Current Payables of $0.0 Mil as of Mar. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Veracyte and its competitors.
Is Veracyte's Other Current Payables too high?
Veracyte's current Other Current Payables is $0.0 Mil. Overall, Veracyte has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Veracyte's Other Current Payables compare to RDNT and SHC?
Veracyte's Other Current Payables of $0.0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Medical Diagnostics & Research company?
A good Other Current Payables depends on the Medical Diagnostics & Research industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Veracyte and its competitors. Veracyte's current Other Current Payables is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veracyte stock overvalued right now?
Based on GuruFocus' analysis, Veracyte (VCYT) is currently considered Significantly Overvalued. The stock's GF Value™ is $38.11, compared to a current price of $58.72 — trading 54.1% above its estimated fair value. The current Other Current Payables is $0.0 Mil. Veracyte's overall GF Score™ is 75/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Veracyte (VCYT), the current Other Current Payables is $0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Veracyte (VCYT) Overvalued in 2026?

Based on GuruFocus' analysis, Veracyte stock appears to be overvalued. The current stock price of $58.72 is trading 54.1% above its estimated GF Value™ of $38.11. GuruFocus considers Veracyte to be Significantly Overvalued.

Key valuation signals for VCYT:

  • Other Current Payables: $0.0 Mil
  • GF Value™: $38.11 vs. price of $58.72 (54.1% above fair value)
  • GF Score™: 75/100 with 7 warning signs

No single metric tells the full story. See the VCYT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Veracyte Business Description

Other Exchanges 12V:Germany
Address 6000 Shoreline Court, Suite 300, South San Francisco, CA, USA, 94080
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).
75GF Score

Get the complete analysis for VCYT

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$58.72
Price
$38.11
GF Value